68136067MU028L0medical innovation,health technology assessment,health economic evaluation,target product profiles,research and development

Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage. Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca

Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio

66183067HM017L0health economic evaluation,health technology assessment,medical innovation,research and development,target product profiles

67194067MU033L0

This study aims to review public information concerning Human papillomavirus (HPV) vaccine that was disseminated through printing media in Thailand. It also examines the knowledge and decision to get vaccinated among people who had exposed and not exposed to the information. Media analysis was performed on articles published in popular health, wome

Attention Deficit and Hyperactivity Disorder (ADHD) is one of the health problems that affect learning, behavior, child development and sociability of school children. If ADHD is detected early and the correct treatment is provided, a patient can recover from the disease and live a normal life. ADHD screening measures currently used have diversity

To develop Health Intervention and Technology Assessment (HITA) capacity in member states, World Health Organization, South East Asia Regional Office (WHO SEARO) allocated funding for HITA capacity building in the region. Sri Lanka, together with Indonesia and Nepal, was selected to be a country case study. The project began in early 2015 and is pa

Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions.   The

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve